We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Testing Newest Focus in Debate Over Follow-on Biologics
Clinical Testing Newest Focus in Debate Over Follow-on Biologics
April 3, 2007
Biotechnology industry leaders are telling House lawmakers that proposed legislation allowing the FDA to approve follow-on biologics should include clear and sound patient safety provisions.